ArticleJournal of Cancer2018
TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway.
Ting-Ting Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this papercites it